Varicella zoster virus vaccine (Sinovac Biotech)

水痘减毒活疫苗（科兴生物）

Report date: 2026/05/02 20:00:18

Base Information

Drug NameVaricella zoster virus vaccine (Sinovac Biotech)
Drug Alias Namevaricella zoster vaccine水痘带状疱疹病毒疫苗Live attenuated varicella vaccineVaricella vaccine, livePROVARIX
ClassificationVaccines > Biological material > Viral vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Development/production technology > Live attenuated vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsChickenpoxVaricella Zoster Virus InfectionHerpesviridae Infections
Global Approved IndicationsVaricella Zoster Virus Infection
Approved Indications in ChinaVaricella Zoster Virus Infection
Original Approved Country/TerritoryMainland China
Original Approved Date2019/12/18
Country/TerritoryVietnamPhilippinesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSinovac Biotech LtdGlaxosmithkline PlcSinovac (Dalian) Vaccine Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinovac (Dalian) Vaccine Technology Co LtdSinovac Biotech Ltd
Inactive CompaniesN/A
Active IndicationsChickenpoxVaricella Zoster Virus InfectionHerpesviridae Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ07BK01
Related LinksWikipediaDrugBank